Acadia Healthcare (NASDAQ:ACHC – Get Free Report) had its price target boosted by investment analysts at Leerink Partners from $30.00 to $33.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage currently has a “market perform” rating on the stock. Leerink Partners’ price objective suggests a potential upside of 12.36% from the company’s previous close.
Several other brokerages have also recently issued reports on ACHC. UBS Group lifted their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 9th. TD Cowen upped their price target on Acadia Healthcare from $30.00 to $36.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Guggenheim boosted their price objective on Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 30th. KeyCorp boosted their price target on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 14th. Finally, Barclays lifted their price objective on shares of Acadia Healthcare from $25.00 to $32.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 30th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, Acadia Healthcare has an average rating of “Hold” and an average target price of $30.69.
View Our Latest Analysis on ACHC
Acadia Healthcare Stock Up 3.5%
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 EPS for the quarter, beating the consensus estimate of $0.35 by $0.03. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The business had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. During the same quarter last year, the firm posted $0.83 earnings per share. The company’s revenue for the quarter was down .4% on a year-over-year basis. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. As a group, analysts forecast that Acadia Healthcare will post 1.55 earnings per share for the current fiscal year.
Institutional Trading of Acadia Healthcare
Several large investors have recently made changes to their positions in ACHC. Allworth Financial LP acquired a new position in shares of Acadia Healthcare during the 2nd quarter valued at about $45,000. Global Retirement Partners LLC purchased a new stake in Acadia Healthcare during the 2nd quarter worth $68,000. Integrated Wealth Concepts LLC purchased a new stake in Acadia Healthcare during the 2nd quarter worth approximately $79,000. Quantbot Technologies LP bought a new position in Acadia Healthcare during the 2nd quarter valued at $88,000. Finally, WINTON GROUP Ltd increased its position in shares of Acadia Healthcare by 1.4% in the 2nd quarter. WINTON GROUP Ltd now owns 255,451 shares of the company’s stock worth $7,543,000 after purchasing an additional 3,449 shares during the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services. The company operates facilities that offer treatment for mental health conditions, substance use disorders and other behavioral health needs. Its services are designed for children, adolescents and adults and may include inpatient psychiatric care, residential treatment, outpatient programs and specialized care.
Acadia’s facilities provide a range of treatment programs, including psychiatric hospitals, addiction treatment centers, eating disorder programs and other specialty behavioral healthcare services.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- Lockheed’s Stock Hasn’t Priced In Its Own Backlog—Boeing’s Might Already Have
- Eli Lilly Keeps Pulling Ahead—Can Novo Nordisk Catch Up?
- Old Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom
- 3 Tech Stocks Positioned for More Upside if the Sector’s Breakout Holds
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
